Clinical trial: Oral drug keeps cancer treatment on track for patients who develop persistently low platelet counts

Дата публикации: 20-07-2026 20:40:01

In a phase 2 clinical trial, Mass General Brigham Cancer Institute researchers found that the oral drug avatrombopag was safe and effective in managing persistent chemotherapy-induced thrombocytopenia (CIT) in more than half of patients with gastrointestinal cancers, offering a potential new option for managing a common and challenging complication of cancer treatment. Their work is published in the Journal of Clinical Oncology.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Successful treatment with gilteritinib for popliteal extramedullary relapse of FLT-3-ITD acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation : a case report and literature review	0	13.23	20-08-2026
2	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
3	EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin	0	5	19-06-2026
4	Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors	0	7	25-06-2026
5	Baseline Extracellular HMGB-1 Levels Associated with Induction Chemotherapy Response in Adult Acute Myeloid Leukemia [version 2; peer review: 2 approved with reservations]	0	7.7	18-08-2026
6	Neoadjuvant Serplulimab with S-1 Plus Oxaliplatin Followed by Adjuvant Serplulimab Significantly Improves EFS in PD-L1-positive, Resectable Gastric or GEJ Adenocarcinoma	5	7	30-06-2026
7	Российские ученые создали препарат для снижения побочных эффектов при лечении рака	5	7	05-07-2026
8	Celltrion Vegzelma Matches Original Drug in Study	0	12.21	14-08-2026
9	В РФ готовят к выпуску первый отечественный препарат против онкозаболевания крови	0	0	25-04-2025
10	New treatment helps achieve a healthier BMI in people with weight dysregulation after brain tumors	5	7	09-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: medicalxpress.com.